Prescribing in renal disease

Australian Prescriber

Volumn 30, Issue 1, 2007, Pages 17-20

  Faull, Randall ^a,b   Lee, Lisa ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

^b UNIVERSITY OF ADELAIDE   (Australia)

Author keywords

Creatinine clearance; Drug therapy; Glomerular filtration rate; Kidney disease

Indexed keywords

ACICLOVIR; ALLOPURINOL; AMISULPRIDE; ANTIVIRUS AGENT; ATENOLOL; CEFAZOLIN; CEFEPIME; CEFTAZIDIME; CIPROFLOXACIN; DIGOXIN; ENOXAPARIN; FAMCICLOVIR; FLUCONAZOLE; GANCICLOVIR; GLIBENCLAMIDE; GLIMEPIRIDE; INSULIN; LAMIVUDINE; MEROPENEM; METFORMIN; MORPHINE; PIPERACILLIN; POTASSIUM SPARING DIURETIC AGENT; SOTALOL; SPIRONOLACTONE; SULFAMETHOXAZOLE; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VALACICLOVIR; VALGANCICLOVIR;

BODY MASS; BODY WEIGHT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DOSE CALCULATION; DRUG DOSE REDUCTION; FUNCTIONAL ASSESSMENT; GLOMERULUS FILTRATION RATE; GOUT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; HYPERKALEMIA; HYPOGLYCEMIA; KIDNEY DISEASE; KIDNEY FUNCTION; LACTIC ACIDOSIS; LOW DRUG DOSE; NAUSEA; PRESCRIPTION; RECOMMENDED DRUG DOSE; REVIEW; SCREENING TEST; SEX DIFFERENCE; URINALYSIS;

EID: 33846912565     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2007.008     Document Type: Review

References (7)

1. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-70.
2. Mathew TH. The Australasian Creatinine Consensus Working Group. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: a position statement. Med J Aust 2005;183:138-41.
3. Wargo KA, Eiland EH 3rd, Hamm W, English TM, Phillippe HM. Comparison of the modification of diet in renal disease and Cockcroft-Gault equations for antimicrobial dosage adjustments. Ann Pharmacother 2006;40:1248-53.
4. Aronoff GR, Berns JS, Brier ME, Golper TA, Morrison G, Singer I, et al. Drug prescribing in renal failure: dosing guidelines for adults. 4th ed. Philadelphia: American College of Physicians-American Society of Internal Medicine; 1999.
5. Nisbet JC, Sturtevant JM, Prins JB. Metformin and serious adverse effects. Med J Aust 2004;180:53-4.
6. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, et al. The effect of spironolactone on morbidity and mortality in patients with severe heart failure: Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-17.
7. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004;351:543-51.